Search for: "Johnson v. Mark" Results 581 - 600 of 1,226
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Jun 2010, 4:43 am by INFORRM
  Speakers include Gill Phillips, Gavin Millar QC, Heather Rogers QC and Mark Stephens. [read post]
5 Jul 2008, 11:05 am
: (IP tango), China: Pfizer loses trade mark action against Jaingsu Lianhuan Pharmaceutical Co over 3D mark: (Rouse & Co International), India: More patents for new forms issued to generics: (Patent Circle), India: Gauri Kamath on drug ‘differential pricing’ in India: (Spicy IP), Mexico: Revised health supplies regulations promise changes for generics: (International Law Office), US: World drug pricing crisis: Congressmen criticise US Trade… [read post]
27 Mar 2012, 8:47 pm by Stu Ellis
Weed specialists Mark Loux of Ohio State and Bill Johnson of Purdue relate in their fact sheet that marestail will emerge from March through June and again from late summer into the fall. [read post]
9 Apr 2009, 9:27 am
KG v President of Gernamn Patent- und Markenamt (IPKat) Geobra Brandstätter assert copyright against vicar Pfarrer Markus Bomhard for using ‘deformed’ Playmobil figurines to depict biblical scenes (IPKat) (The IP Factor) Bundesgerichtshof on when a trade mark is distinctive enough to qualify for registration: STREETBALL case (Class 46) Still no infringement of Tuc cracker shape, says German appellate court (Class 46)   Greece Well-known MOUYER… [read post]
3 Feb 2024, 9:52 am by Marty Lederman
 I’ve marked in boldface, and labeled as [1] and [2], the two separate clauses of Section 3 that identify particular officers and other government officials. [read post]
4 Aug 2016, 1:49 pm by Sandy Levinson
Both Mark Graber and Gerard Magliocca make important points. [read post]
31 Aug 2016, 12:29 pm by Emma Durand-Wood
Dangerous drugs law firm Hissey Kientz noted that Johnson & Johnson once offered a plaintiff more than million dollars to drop her baby powder/ovarian cancer lawsuit; described a study that identifies a potential link between PPIs and dementia; and shared details of the FDA’s long-overdue update to fluoroquinolone (FLQ) warning labels. [read post]